Back to User profile » Prof. Dr. Abdel Naser Zaid
Papers published by Prof. Dr. Abdel Naser Zaid:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A Comprehensive Review on Pharmaceutical Film Coating: Past, Present, and Future
Zaid AN
Drug Design, Development and Therapy 2020, 14:4613-4623
Published Date: 29 October 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Identification of substandard drug products using electronic tongue: cefdinir suspension as a pilot example
Abu-Khalaf N, Zaid AN, Jaradat N, Alkilany AM, Abulateefeh SR, Al Ramahi R, Ghanem M
Drug Design, Development and Therapy 2019, 13:3249-3258
Published Date: 16 September 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Evaluating the potential use of electronic tongue in early identification and diagnosis of bacterial infections
Al Ramahi R, Zaid AN, Abu-Khalaf N
Infection and Drug Resistance 2019, 12:2445-2451
Published Date: 7 August 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pharmacodynamic testing and new validated HPLC method to assess the interchangeability between multi-source orlistat capsules
Zaid AN, Zohud N, E'layan B, Aburadi T, Jaradat N, Ali I, Hussein F, Ghanem M, Qaddomi A, Abu Zaaror Y
Drug Design, Development and Therapy 2017, 11:3291-3298
Published Date: 21 November 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Single-walled carbon nanotubes-ciprofloxacin nanoantibiotic: strategy to improve ciprofloxacin antibacterial activity
Assali M, Zaid AN, Abdallah F, Almasri M, Khayyat R
International Journal of Nanomedicine 2017, 12:6647-6659
Published Date: 7 September 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorthiazide, among Palestinian hypertensive patients
Zaid AN, Ghanem M, Shweiki D, Shtewi H, Shaheen R, Al Helaly S, Khayyat Z, Al Ramahi R, Zyoud SH
Therapeutics and Clinical Risk Management 2016, 12:1425-1432
Published Date: 19 September 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Investigation of the bioequivalence of montelukast chewable tablets after a single oral administration using a validated LC-MS/MS method
Zaid AN, Abualhasan MN, Watson DG, Mousa A, Ghazal N, Bustami R
Drug Design, Development and Therapy 2015, 9:5315-5321
Published Date: 23 September 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Comparative fasting bioavailability of two clopidogrel formulations in healthy Mediterranean volunteers: an in vitro–in vivo correlation
Zaid AN, Al Ramahi R, Bustami R, Mousa A, Khasawneh S
Drug Design, Development and Therapy 2015, 9:2359-2365
Published Date: 24 April 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Formulation and in vitro and in vivo evaluation of film-coated montelukast sodium tablets using Opadry® yellow 20A82938 on an industrial scale
Zaid AN, Natour S, Qaddomi A, Abu Ghoush A
Drug Design, Development and Therapy 2013, 7:83-91
Published Date: 7 February 2013